Commentary to: Cancer and treatment specific incidence rates of immune related adverse events induced by immune checkpoint inhibitors: a systematic review
Br J Cancer
.
2024 Dec 16.
doi: 10.1038/s41416-024-02933-y.
Online ahead of print.
Authors
Alessandro Villa
1
2
,
Bryan J Schneider
3
,
Christina Lacchetti
4
,
Thomas K Oliver
4
,
Douglas E Peterson
5
Affiliations
1
Oral Medicine, Oral Oncology and Dentistry, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA.
[email protected]
.
2
Department of Orofacial Sciences, School of Dentistry, University of California San Francisco, San Francisco, CA, USA.
[email protected]
.
3
University of Michigan Health System, Ann Arbor, MI, USA.
4
American Society of Clinical Oncology, Alexandria, VA, USA.
5
School of Dental Medicine, UConn Health, Farmington, CT, USA.
PMID:
39681618
DOI:
10.1038/s41416-024-02933-y
No abstract available
Publication types
Comment